Results

Total Results: 162 records

Showing results for "prostate cancer screening".
Users also searched for: psa

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - Cancer of the prostate is the second most common cancer and the second leading cause of cancer deaths … The prostate cancer antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancersof the prostate is the second most common cancer and the second leading cause of cancer deaths in men … Randomized Study of Screening for Prostate Cancer. … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men
  2. 04-E029-1 Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - screening. … Indeed, more than half of prostate cancers detected by PSA screening are expected to be early-stage, … of the Prostate Strategic Urologic Research Endeavor). … of the Prostate Urologic Research Endeavor (CaPSURE) database, 5 the National Cancer Database (NCDB) … Similarly, black patients with prostate cancer were at higher risk for death due to prostate cancer compared
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
    April 01, 2013 - “A recent evidence review found no reduction in prostate cancer-specific mortality based on tPSA screening … Maybe it is enough to simply state that the use and effectiveness of prostate cancer screening with … This may or may not influence the sensitivity and specificity of prostate cancer screening with PSA. … cancer screening. … cancer screening.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … 1) Baseline PSA 2) Gleason score 3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
    July 03, 2012 - Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment Source: http … Multigene Panels in Prostate Cancer Risk Assessment. … A summary of the genetics of prostate cancer as well as of its heritability would have been welcome, … part of the introduction has been re- organized, to make information on genetics of prostate cancer … We have added a reference to the Vickers paper in JCO to the summary of prostate cancer screening in
  7. Brooks_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
    January 01, 2012 - Cancer Screening  Guidelines Durado  Brooks, M.D., M.P.H. … with prostate cancer screening.   … findin prostate  cancer at an earlier stage. • Screening might lower a man’s risk of dying from   … prostate cancer — but this is not entirely  clear. • Screening gives many false-­‐negative  and …  Cancer  Screening  Guidelines for Health Care Professionals issued by  the American Cancer
  8. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
    July 29, 2010 - , to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity … cancer screening tests vs. screening by PSA testing, other screening methods, or no screening. … May lead to unnecessary follow-up for men who are asymptomatic or have slowly progressing prostate cancerProstate cancer is among the most frequently diagnosed and deadliest cancers among men in the U.S. … Cancer: Future Research Needs PCA3 Testing for the Diagnosis and Management of Prostate Cancer
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - Currently, most prostate cancer in men in the United States is found by prostate-specific antigen ( … PSA) screening. … It was projected that in 2010 over 217,000 men would be diagnosed with cancer of the prostate and about … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … patients, prostate cancer screening standards, treatment, et cetera.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
    December 01, 2011 - cancer screening and treatment decisions. … At some point should address the issue of nomenclature: whether some minimal‐risk prostate cancersof the Prostate Strategic Urologic 2. … cancer incidence after the introduction of PSA-based screening is among low-stage tumors. … cancer from low-risk prostate cancer that is capable of progressing to symptomatic or life- threatening
  11. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - Men with low-grade prostate cancers had a minimal risk of dying from prostate cancer (7 percent with … Prostate cancers not detected by PSA testing. … Regional differences Medium • Physician availability, prostate cancer screening, incidence, and mortality … Low • The risk of overall or prostate cancer death over 10 years for PSA-detected prostate cancers according … High • Screening with PSA testing detects more prostate cancer and cancers of smaller volume, earlier
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
    December 16, 2014 - This should be no surprise given the protracted course of most prostate cancers. … We have added a statement on The Cancer of the Prostate Risk Assessment (CAPRA) with all appropriate … and did not provide separate results for men with T1 and or T2 prostate cancers) Sheets et al. 201229 … Limitations of basing screening policies on screening trials: The US Preventive Services Task Force … and Prostate Cancer Screening.
  13. effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/13.html
    June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer Treatment Options Archived … PREV Introduction Prostate Cancer Treatment Options What Is Important … cancer (available at http://effectivehealthcare.ahrq.gov) Understanding Your Treatment Options … Page 13 of 24 Options for Treating Prostate Cancer Now   You have many … No one treatment is considered best for treating clinically localized prostate cancer because each man
  14. Schwitzer_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
    July 23, 2012 - Slide 14: Screening  Stories  Receive theWorst News  Coverage: Prostate Cancer (1 of 2) • This … excerpt comes from  an article, “Cancer Society Casts Doubt on Value of Prostate  Cancer Test,”1 … cancer.” … Slide 15: Screening  Stories  Receive theWorst News  Coverage: Prostate Cancer (2 of 2) • Balance … cancer screening
  15. effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/21.html
    June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer What Is Important Archived … "Take your time, get the facts, and make a ‘game plan’" PREV Introduction ProstateCancer Treatment Options What Is Important Talk With Your Doctor NEXT … Printed from: Knowing your options: a decision aid for men with clinically localized prostate cancercancer.
  16. effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/10.html
    June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer Treatment Options Archived … Printed from: Knowing your options: a decision aid for men with clinically localized prostate cancercancer do not need immediate treatment. … For most men with clinically localized prostate cancer, there is time to think about your options. … cancer, including details about treatment options.
  17. effectivehealthcare.ahrq.gov/products/decision-aids
    September 09, 2011 - Aid Archived Knowing Your Options: A Decision Aid for Men With Clinically Localized ProstateCancer March 09, 2016 Decision Aid Archived Is Lung Cancer Screening
  18. effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
    November 12, 2013 - cancer. . … Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. … EAU guidelines on prostate cancer. … Information and patient participation in screening for prostate cancer. … cancer screening.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
    September 18, 2023 - Key Question Tumor Cell-free DNA for Cancer Screening 1 Key Question Tumor Cell-free DNA for Cancer … Screening Background Multicancer early detection (MCED) tests have an intriguing potential for … An economic model published in August 2023 found that USPSTF-recommended cancer screenings for breast … tests compared to alternative screening approaches? … The aggregate value of cancer screenings in the United States: full potential value and value considering
  20. effectivehealthcare.ahrq.gov/health-topics/mens-health
    December 16, 2014 - Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review Systematic … Archived December 16, 2014 Comparative Effectiveness of Therapies for Clinically Localized ProstateCancer: An Update of a 2008 Comparative Effectiveness Review Research Protocol Archived

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: